Clinical Trial Update: Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating corticodependent or corticoresistant brain radionecrosis after radiotherapy for brain metastases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Radionecrosis

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Radionecrosis of Brain, Brain Metastases | Phase 3 | Status: RECRUITING